Three years later: Lessons learned and the unknown future of the IRA

Get direct insights from payers on drug pricing, formulary shifts, and contracting strategies ahead of the 2026 rollout.

Relevant.

Timely.

Actionable.

Prepare your access strategy before payers finalize 2026 decisions. Only 15 manufacturer spots are available. Secure your participation before enrollment closes.

Why Participate?

The Inflation Reduction Act (IRA) is already reshaping how drugs are priced, evaluated, and accessed. But how are payers responding behind the scenes?

IRA Payer Insights Survey 5.0 offers manufacturers exclusive access to relevant feedback from national and regional payer decision-makers—insights that can directly shape your 2026 market access strategy.

You’ll learn:

  • How payers are adjusting formulary and rebate strategies
  • What changes are expected in contracting and premiums
  • Where utilization management policies are heading

What’s Included:

Research Report:
Summary with qualitative and quantitative insights

Confidential Questions:
Submit two customized questions relevant to your business

Syndicated, Individualized Readout:
One-hour session with your team focused on your results

General Read-Outs:
Three group sessions with panel Q&A and recordings

To learn more about how to participate, fill out the form below.

Participation is limited.

"*" indicates required fields

Name*
This field is for validation purposes and should be left unchanged.

Don’t Miss Out.

Gain the strategic insights you need to stay ahead of IRA 2026 changes. Align with payer expectations and strengthen your market access strategy before it’s too late.